Dentsply International Inc. (XRAY) Shares Bought by Emerald Advisers Inc. PA
Emerald Advisers Inc. PA boosted its position in shares of Dentsply International Inc. (NASDAQ:XRAY) by 10.6% during the second quarter, Holdings Channel reports. The institutional investor owned 114,120 shares of the company’s stock after buying an additional 10,920 shares during the period. Emerald Advisers Inc. PA’s holdings in Dentsply International were worth $7,080,000 at the end of the most recent quarter.
Several other institutional investors have also recently made changes to their positions in XRAY. Glenmede Trust Co. NA boosted its position in shares of Dentsply International by 92.5% in the first quarter. Glenmede Trust Co. NA now owns 6,918 shares of the company’s stock worth $425,000 after buying an additional 3,325 shares in the last quarter. Nisa Investment Advisors L.L.C. boosted its position in shares of Dentsply International by 105.8% in the first quarter. Nisa Investment Advisors L.L.C. now owns 44,942 shares of the company’s stock worth $2,770,000 after buying an additional 23,101 shares in the last quarter. Los Angeles Capital Management & Equity Research Inc. purchased a new position in shares of Dentsply International during the first quarter worth $1,242,000. Ngam Advisors L.P. boosted its position in shares of Dentsply International by 357.1% in the first quarter. Ngam Advisors L.P. now owns 87,622 shares of the company’s stock worth $5,400,000 after buying an additional 68,453 shares in the last quarter. Finally, TIAA CREF Investment Management LLC boosted its position in shares of Dentsply International by 47.8% in the first quarter. TIAA CREF Investment Management LLC now owns 857,170 shares of the company’s stock worth $52,827,000 after buying an additional 277,279 shares in the last quarter. 94.58% of the stock is currently owned by institutional investors.
Shares of Dentsply International Inc. (NASDAQ:XRAY) traded up 1.00% during midday trading on Friday, hitting $59.67. The stock had a trading volume of 1,351,238 shares. Dentsply International Inc. has a 52-week low of $53.43 and a 52-week high of $65.83. The company’s 50 day moving average is $60.10 and its 200 day moving average is $61.39.
Dentsply International (NASDAQ:XRAY) last released its quarterly earnings data on Friday, August 5th. The company reported $0.76 earnings per share for the quarter, topping analysts’ consensus estimates of $0.70 by $0.06. The firm earned $1.02 billion during the quarter, compared to analyst estimates of $1.03 billion. Dentsply International had a return on equity of 9.18% and a net margin of 11.99%. The business’s quarterly revenue was up 46.4% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.73 earnings per share. Analysts anticipate that Dentsply International Inc. will post $2.76 earnings per share for the current fiscal year.
The company also recently declared a dividend, which will be paid on Friday, October 14th. Investors of record on Friday, September 30th will be paid a dividend of $0.0775 per share. The ex-dividend date of this dividend is Wednesday, September 28th. Dentsply International’s payout ratio is presently 14.49%.
A number of equities analysts recently weighed in on XRAY shares. Piper Jaffray Cos. started coverage on Dentsply International in a report on Monday, June 13th. They set an “overweight” rating and a $70.00 price objective on the stock. Credit Suisse Group AG reissued a “buy” rating on shares of Dentsply International in a report on Sunday, June 26th. Barrington Research cut Dentsply International from an “outperform” rating to a “market perform” rating in a report on Monday, August 8th. Zacks Investment Research cut Dentsply International from a “buy” rating to a “hold” rating in a research note on Monday, August 8th. Finally, Jefferies Group reaffirmed a “buy” rating on shares of Dentsply International in a research note on Wednesday, August 17th. Six equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The stock has a consensus rating of “Buy” and an average target price of $66.91.
In related news, VP Rainer Berthan sold 5,000 shares of the stock in a transaction that occurred on Tuesday, September 6th. The stock was sold at an average price of $61.12, for a total transaction of $305,600.00. Following the completion of the transaction, the vice president now directly owns 34,370 shares of the company’s stock, valued at $2,100,694.40. The sale was disclosed in a filing with the SEC, which is available through this link. Also, SVP Maureen J. Macinnis sold 17,650 shares of the stock in a transaction that occurred on Tuesday, August 23rd. The shares were sold at an average price of $60.61, for a total value of $1,069,766.50. Following the transaction, the senior vice president now directly owns 19,630 shares of the company’s stock, valued at $1,189,774.30. The disclosure for this sale can be found here. Corporate insiders own 2.20% of the company’s stock.
Dentsply International Company Profile
DENTSPLY SIRONA Inc, formerly DENTSPLY International Inc, designs, develops, manufactures and markets a range of consumable dental products for the professional dental market. The Company also manufactures and markets consumable medical device products consisting mainly of urological catheters and certain surgical products.
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dentsply International Inc. (NASDAQ:XRAY).
Receive News & Ratings for Dentsply International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dentsply International Inc. and related companies with MarketBeat.com's FREE daily email newsletter.